Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)Active Not Recruiting
NCT06687980Phase 3Updated Jul 2, 2026
Sponsor: Sanofi
Lichen Simplex Chronicus
United States, Argentina, Belgium, Canada, Chile +12 more
Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Clinical StudyEnrolling By Invitation
NCT06914908Phase 2Updated Jul 2, 2026
Sponsor: Sanofi
Chronic Rhinosinusitis With Nasal Polyps
United States, Argentina, Belgium, Bulgaria, Poland +1 more
Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on DialysisTerminated
NCT02859896Phase 3Updated Jul 2, 2026
Sponsor: Sanofi
Secondary Hyperparathyroidism-Chronic Kidney Disease
United States, Chile
Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell CarcinomaCompleted
NCT00183820Phase 2Updated Jul 1, 2026
Sponsor: University of Southern California
Testicular Cancer · Germ Cell Neoplasm
United States
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular DegenerationRecruiting
NCT07215234Phase 1, Phase 2Updated Jul 1, 2026
Sponsor: Sanofi
Geographic Atrophy
United States, Australia
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting
NCT07184931Phase 3Updated Jul 1, 2026
Sponsor: Sanofi
Crohn's Disease
United States, Argentina, Australia, Austria, Belgium +26 more
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaActive Not Recruiting
NCT06676319Phase 2Updated Jul 1, 2026
Sponsor: Sanofi
Asthma
United States, Argentina, Belgium, Brazil, Canada +17 more
A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May HaveActive Not Recruiting
NCT05831176Phase 2Updated Jul 1, 2026
Sponsor: Regeneron Pharmaceuticals
Eosinophilic Gastritis (EoG) · Eosinophilic Duodenitis (EoD) · Eosinophilic Gastrointestinal Disease (EGID) · Eosinophilic Gastroenteritis
United States, Canada, Italy, Japan
Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple MyelomaCompleted
NCT06203912Phase 1Updated Jul 1, 2026
Sponsor: Elvira Umyarova
Recurrent Multiple Myeloma · Refractory Multiple Myeloma
United States
Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 DiabetesRecruiting
NCT06791291Phase 2Updated Jul 1, 2026
Sponsor: Sanofi
Type 1 Diabetes Mellitus
Japan
Quantifying the Burden of Type 2 (T2) Inflammation in AsthmaNot Yet Recruiting
NCT07675044N/AUpdated Jun 30, 2026
Sponsor: Icahn School of Medicine at Mount Sinai
Asthma · Type 2 Asthma
United States
Managed Access Program of Venglustat in Pediatric and Adult Patients With Type 3 Gaucher Disease (GD3).Available
NCT07675031N/AUpdated Jun 30, 2026
Sponsor: Sanofi
Type 3 Gaucher Disease
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft DysfunctionRecruiting
NCT06082037Phase 3Updated Jun 29, 2026
Sponsor: Sanofi
Lung Transplant Rejection
United States, Australia, Austria, Belgium, Canada +14 more
Frexalimab in Preservation of Endogenous Insulin Secretion Compared to Placebo in Adults, Adolescents and Children on Top of Insulin Therapy (FABULINUS)Active Not Recruiting
NCT06111586Phase 2Updated Jun 29, 2026
Sponsor: Sanofi
Type 1 Diabetes Mellitus
United States, Austria, Belgium, Canada, Czechia +11 more
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell CarcinomaRecruiting
NCT04975152Phase 1Updated Jun 25, 2026
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Merkel Cell Carcinoma · Cutaneous Squamous Cell Carcinoma
United States
Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)Completed
NCT03088540Phase 3Updated Jun 25, 2026
Sponsor: Regeneron Pharmaceuticals
Carcinoma，Non-Small-Cell Lung · Lung Carcinomas, Non-Small-Cell · Non-small-cell Lung Carcinoma · Nonsmall Cell Lung Cancer
Australia, Belarus, Brazil, Bulgaria, Chile +19 more
NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-IberdomideRecruiting
NCT05558319Phase 3Updated Jun 25, 2026
Sponsor: PETHEMA Foundation
Newly Diagnosed Multiple Myeloma
Spain
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With AchondroplasiaTerminated
NCT06067425Phase 2Updated Jun 25, 2026
Sponsor: Sanofi
Osteochondrodysplasia
Australia, China, Italy, South Korea, Spain
A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD)Active Not Recruiting
NCT04848779N/AUpdated Jun 24, 2026
Sponsor: Sanofi
Glycogen Storage Disease Type II
United States, Belgium, France, Germany, Italy +4 more
A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry DiseaseActive Not Recruiting
NCT05280548Phase 3Updated Jun 24, 2026
Sponsor: Sanofi
Fabry Disease
United States, Austria, Canada, China, Czechia +14 more
Fabry Disease Registry & Pregnancy Sub-registryRecruiting
NCT00196742N/AUpdated Jun 23, 2026
Sponsor: Genzyme, a Sanofi Company
Fabry Disease
United States, Argentina, Australia, Belgium, Brazil +39 more
Sarilumab Efficacy and Safety in Adults With Early Polymyalgia RheumaticaRecruiting
NCT07286214Phase 4Updated Jun 23, 2026
Sponsor: Sanofi
Polymyalgia Rheumatica
United States, Canada
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney TransplantationRecruiting
NCT07412470Phase 2, Phase 3Updated Jun 23, 2026
Sponsor: Sanofi
Kidney Transplant Rejection
United States, Argentina, Australia, Belgium, Chile +6 more
A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.Completed
NCT07272629Phase 1Updated Jun 23, 2026
Sponsor: Sanofi
Cardiac Repolarization · Healthy Volunteers
United States
A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))Active Not Recruiting
NCT05731128Phase 2Updated Jun 23, 2026
Sponsor: Sanofi
Colitis Ulcerative
United States, Argentina, Canada, Chile, Japan +6 more

Previous page Next page